Position in ARGX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$1,460
-$1,062 QoQ
Shares Held
2
-33.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Smithfield Trust Co holds $563,573 across 10 Biotechnology names. ARGX ranks #8 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
332 | $256,516 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
503 | $224,609 | |
| 3 | INCY |
Incyte Corp
|
323 | $30,400 | |
| 4 | RPRX |
Royalty Pharma plc
|
603 | $28,925 | |
| 5 | CYTK |
Cytokinetics Inc
|
155 | $10,216 | |
| 6 | TECH |
BIO-TECHNE Corp
|
148 | $7,734 | |
| 7 | MDXG |
Mimedx Group, Inc.
|
606 | $2,393 | |
| 8 | ARGX |
Argenx SE
This page
|
2 | $1,460 |
All Filings in ARGX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,460 | 2 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $2,522 | 3 | Shares | Sole | 2026-02-09 | |
| 2025-06-30 | $22,600 | 41 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $22,490 | 38 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $25,830 | 42 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $22,767 | 42 | Shares | Sole | 2024-11-12 | |
| 2024-03-31 | $787 | 2 | Shares | Sole | 2024-05-07 | |
| No filing history on record for this holder in this stock. | ||||||